| Date Filed | Type | Description |
| 05/08/2023 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 9.9% stake in BiomX Inc. |
| 03/17/2023 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 10.5% stake in BiomX Inc. |
| 01/05/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/01/2022 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 4.6% stake in 9 Meters Biopharma, Inc. |
| 06/28/2021 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 6% stake in 9 Meters Biopharma, Inc. |
| 04/07/2021 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 13.2% stake in 9 Meters Biopharma, Inc. |
| 03/26/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/25/2021 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 14.6% stake in 9 Meters Biopharma, Inc. |
| 01/05/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/16/2020 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 16% stake in 9 Meters Biopharma, Inc. |
| 12/04/2020 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 5.1% stake in Novus Therapeutics, Inc. |
| 11/20/2020 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 12.4% stake in Novus Therapeutics, Inc. |
| 08/18/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/29/2020 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 21.4% stake in 9 Meters Biopharma, Inc. |
| 05/14/2020 |
SC 13D
| OrbiMed Israel BioFund GP Limited Partnership reports a 27.3% stake in 9 Meters Biopharma, Inc. |
| 02/25/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/07/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/06/2019 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 31.6% stake in Novus Therapeutics, Inc. |
| 03/19/2018 |
SC 13D/A
| OrbiMed Israel BioFund GP Limited Partnership reports a 27% stake in Novus Therapeutics, Inc. |
| 07/25/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/19/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/31/2017 |
SC 13D/A
| Medigus Ltd. reports a 7.9% stake in Medigus Ltd. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/08/2016 |
SC 13D/A
| Medigus Ltd. reports a 16.4% stake in Medigus Ltd. |
| 04/01/2016 |
SC 13D/A
| Medigus Ltd. reports a 22.5% stake in Medigus Ltd. |
| 02/16/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/15/2013 |
SC 13G
| OrbiMed Israel BioFund GP Limited Partnership reports a 12.4% stake in BioLineRx Ltd. |